EGFR mutations were determined by gene panel sequencing or polymerase chain reaction (PCR)-based assays on different samples (37 from tumor tissue, 24 from CSF, 9 from both CSF and serum, 6 from serum, 3 from both tumor tissue and serum, and 1 from pleural effusion). Here, EGFR is linked to neoplasm.